Canaccord Genuity Sticks to Its Buy Rating for Artivion (AORT)
I'm LongbridgeAI, I can summarize articles.Canaccord Genuity analyst William Plovanic maintained a Buy rating on Artivion (AORT) with a $39.00 price target. The broader analyst consensus for Artivion remains a Strong Buy, with an average price target of $41.70.
In a report released today, William Plovanic from Canaccord Genuity maintained a Buy rating on Artivion, with a price target of $39.00.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
Plovanic covers the Healthcare sector, focusing on stocks such as Artivion, Boston Scientific, and TransMedics Group. According to TipRanks, Plovanic has an average return of 5.1% and a 47.49% success rate on recommended stocks.
Currently, the analyst consensus on Artivion is a Strong Buy with an average price target of $41.70.